MPG.eBooks - Search Results - "Immunologic Factors / Therapeutic Use"

1

Drug class review : targeted immune modulators : final update 3 report

by Thaler, Kylie J.
Published 2012

Oregon Health & Science University

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

2

Drug class review : targeted immune modulators : final update 3 report

by Thaler, Kylie J.
Published 2012

Oregon Health & Science University

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

3

Immunomodulatory treatments with intravenous immunoglobulin

by Kornør, Hege, Hammerstrøm, Karianne Thune, Gundro Brurberg, Kjetil, Klemp, Marianne
Published 2008

Kunnskapssenter

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

4

Comparative clinical and cost-effectiveness of drug therapies for relapsing-remitting multiple sclerosis : project protocol

Published 2012

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

5

Targeted immune modulators : final report update 2

by Gartlehner, Gerald
Published 2009

Oregon Health & Science University

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

6

Recommendations for drug therapies for relapsing-emitting multiple sclerosis

Published 2013

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

7

Recommendations for drug therapies for relapsing-emitting multiple sclerosis

Published 2013

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

8

Second-line therapy for patients with relapsing-remitting multiple sclerosis : a review of guidelines

by Li, Ke Xin, Picheca, Lory
Published 2019

CADTH

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

9

Clinical review report: Dupilumab (Dupixent) (Sanofi genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of patients aged 12 years and old...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

10

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

11

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

12

Diagnosis and management of infantile hemangioma

by Chinnadurai, Sivakumar
Published 2016

Agency for Healthcare Research and Quality

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

13

Drug class review on targeted immune modulators : final report

by Gartlehner, Gerald
Published 2006

Oregon Health & Science University

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

14

Drug class review on targeted immune modulators : final report

by Gartlehner, Gerald
Published 2006

Oregon Health & Science University

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

15

Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness

by Young, Calvin, Campbell, Kaitryn
Published 2019

CADTH

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

16

Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness

by Young, Calvin, Campbell, Kaitryn
Published 2019

CADTH

Subjects: “...Immunologic Factors / therapeutic use...”

Narrow Search